Camurus

📍 Lund, Sweden🗓 Founded 1991👥 192 employees💰 Last funded May 2015
Pharmaceutical Manufacturing🌐 camurus.com
Website LinkedIn
Camurus is a Swedish science-led biopharmaceutical company committed to developing and commercializing innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of opioid dependence and chronic pain, rare diseases, oncology and supportive care, which are developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1991
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Camurus?
Camurus has 1 investors on record on gritt.io.
When did Camurus last raise funding?
The most recent investment in Camurus recorded on gritt.io was in May 2015.
When was Camurus founded?
Camurus was founded in 1991.
What industry is Camurus in?
Camurus operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Camurus based?
Camurus is headquartered in Lund, Sweden.